Radiance Therapeutics to Attend LSI USA '24 Emerging Medtech Summit in Dana Point, CA

Radiance Therapeutics, Inc., a leader in ophthalmic device innovation, has announced its participation at the LSI USA '24 Emerging Medtech Summit. The event, focused on the latest in medtech, will host Radiance Therapeutics’ CEO, Laurence Marsteller MD, in Dana Point, California, from March 18-22, 2024. This summit aims to connect emerging medtech companies with investors for potential partnerships and investments.

At the summit, Dr. Laurence Marsteller will showcase Radiance Therapeutics' recent advances, particularly its efforts to revolutionize ophthalmic healthcare. The company has recently reached significant milestones, including receiving US FDA 510(k) regulatory clearance and a US patent for its technologies. These achievements not only secure intellectual property rights for Radiance but also facilitate entry into the global medical device market.

Dr. Marsteller expressed enthusiasm about the prospects the summit holds for fostering industry relationships and highlighting the potential of beta therapy in ophthalmic treatments. The event serves as a platform for the company to explore investment opportunities and partnerships, aiming to further its mission in improving ophthalmic healthcare.